Phase I and pharmacokinetic studies of erlotinib administered concurrently with radiotherapy for children, adolescents, and young adults with high-grade glioma. [electronic resource]
Producer: 20090720Description: 701-7 p. digitalISSN:- 1078-0432
- Adolescent
- Adult
- Anticonvulsants -- pharmacology
- Brain Neoplasms -- drug therapy
- Child
- Child, Preschool
- Combined Modality Therapy
- Erlotinib Hydrochloride
- Female
- Glioma -- drug therapy
- Humans
- Male
- Maximum Tolerated Dose
- Protein Kinase Inhibitors -- administration & dosage
- Quinazolines -- administration & dosage
- Young Adult
No physical items for this record
Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.